2024-03-29T04:55:42Z
http://www.ijcto.org/index.php/IJCTO/oai
oai:ojs.ijcto.org:article/78
2014-04-12T11:23:44Z
IJCTO:EDITORIAL
cam 3u
"140215 2014 eng "
dc
The openness of pluripotent epigenome - Defining the genomic integrity of stemness for regenerative medicine
Parsons, Xuejun H; San Diego Regenerative Medicine Institute;
California Consortium for Regenerative Medicine Startup;
Xcelthera
Stem Cell
<p>This article is an editorial, and it doesn't include an abstract. Full text of this article is available in <a href="/index.php/IJCTO/article/view/Parsons/ijcto.0201.14html" target="_blank"><strong>HTML</strong></a> and <a href="/index.php/IJCTO/article/view/Parsons/ijcto.0201.14pdf" target="_blank"><strong>PDF</strong></a>.</p><p align="left"><strong>Cite this article as:</strong> Parsons XH. The openness of pluripotent epigenome - Defining the genomic Integrity of stemness for regenerative medicine. <em>Int J Cancer Ther Oncol</em> 2014; <strong>2</strong>(1):020114.</p><p><strong>DOI:</strong> <a href="http://dx.doi.org/10.14319/ijcto.0201.14" target="_blank">http://dx.doi.org/10.14319/ijcto.0201.14</a></p>
International Journal of Cancer Therapy and Oncology
2014-02-23 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Parsons
International Journal of Cancer Therapy and Oncology; Vol 2, No 1 (2014): January - March
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/13
2014-03-15T21:50:10Z
IJCTO:EDITORIAL
cam 3u
"130909 2013 eng "
dc
Notes of the editorial board on the role of medical physics in radiotherapy
Ulmer, Waldemar; Goettingen MPI of Physics,Goettingen and Klinikum Munich, Germany.
Medical Physics; Particle Therapy
This article is an editorial, and it doesn't include an abstract. Full text of this article is available in <a href="/index.php/IJCTO/article/view/Ulmer/ijcto.0101.4html" target="_blank">HTML</a> or <a href="/index.php/IJCTO/article/view/Ulmer/ijcto.0101.4pdf" target="_blank">PDF</a>.<br /><div><p><strong>Cite this article as</strong>:<br />Ulmer W. Notes of the editorial board on the role of medical physics in radiotherapy. <em>Int J Cancer Ther Oncol</em> 2013;<strong>1</strong>(1):01014. <br /><strong>DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0101.4" target="_blank">10.14319/ijcto.0101.4</a></p></div>
International Journal of Cancer Therapy and Oncology
2013-10-10 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Ulmer
International Journal of Cancer Therapy and Oncology; Vol 1, No 1 (2013): September - October
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/497
2016-01-03T12:18:13Z
IJCTO:EDITORIAL
cam 3u
"150927 2015 eng "
dc
High Impact Papers from July – September, 2014
Editorial Office, IJCTO
<p>High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em> completes the publication time period of 12 months.</p><p>Following articles are recognized as <strong>High Impact Papers</strong> from <strong><a href="/index.php/IJCTO/issue/view/14">July - September, 2014</a></strong>:</p><p> </p><p>Barbosa NA, da Rosa LAR, de Menezes AF, Reis JP, Facure A, Braz D. Assessment of ocular beta radiation dose distribution due to 106Ru/106Rh brachytherapy applicators using MCNPX Monte Carlo code. Int J Cancer Ther Oncol 2014; 2(3):02038. <br /><strong>DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0203.8">10.14319/ijcto.0203.18</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/Barbosa">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/Barbosa/ijcto.0203.8pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=xzTeO3YAAAAJ&btnA=1&citation_for_view=xzTeO3YAAAAJ:2osOgNQ5qMEC">Citations</a></strong></p><p> </p><p>Chaikh A, Giraud JY, Balosso J. A 3D quantitative evaluation for assessing the changes of treatment planning system and irradiation techniques in radiotherapy. Int J Cancer Ther Oncol 2014; 2(3):02033. <strong>DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0203.3">10.14319/ijcto.0203.3</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/0203.3">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/0203.3/ijcto.0203.3pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=xzTeO3YAAAAJ&btnA=1&citation_for_view=xzTeO3YAAAAJ:u-x6o8ySG0sC">Citations</a></strong></p><p><strong><br /></strong></p><p><strong></strong>Can an alternative backround-corrected [18F] fluorodeoxyglucose (FDG) standard uptake value (SUV) be used for monitoring tumor local control following lung cancer stereotactic body radiosurgery? <strong><br />DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0203.17">10.14319/ijcto.0203.17</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/0203.17">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/0203.17/ijcto.0203.17pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=xzTeO3YAAAAJ&btnA=1&citation_for_view=xzTeO3YAAAAJ:9yKSN-GCB0IC">Citations</a></strong></p><p> </p><p>(High impact papers from <strong><a href="/index.php/IJCTO/issue/view/15">October-December, 2014</a></strong> will be recognized in the next <em>Issue</em> of the IJCTO)</p>
International Journal of Cancer Therapy and Oncology
2015-09-25 00:00:00
http://www.ijcto.org/index.php/IJCTO/article/view/impact0203
International Journal of Cancer Therapy and Oncology; Vol 3, No 3 (2015): July - September
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/232
2014-12-13T14:36:24Z
IJCTO:EDITORIAL
cam 3u
"141031 2014 eng "
dc
Acknowledgement to Reviewers
Office, Editorial
<p align="center"><strong><span style="font-size: medium;">Acknowledgement to Reviewers</span></strong></p><p><span style="font-size: medium;"><strong>The editorial board of International Journal of Cancer Therapy and Oncology (IJCTO) wishes to acknowledge the help of reviewers who have generously contributed their valuable time and efforts during the period September 2013–October 2014 in the appraisal of manuscripts submitted to the IJCTO</strong>. </span></p><p><span style="font-size: medium;">Abdulhamid Chaikh (France)</span></p><p><span style="font-size: medium;">Alok Singh (USA)</span></p><p><span style="font-size: medium;">Anamika Basu (USA)</span></p><p><span style="font-size: medium;">Anish Banerjee (India)</span></p><p><span style="font-size: medium;">Antonella Fogliata (Switzerland)</span></p><p><span style="font-size: medium;">Arun Oinam (India)</span></p><p><span style="font-size: medium;">Birendra Kumar Rout (India)</span></p><p><span style="font-size: medium;">Brindha Subramanian (Australia)</span></p><p><span style="font-size: medium;">Charles Bloch (USA)</span></p><p><span style="font-size: medium;">Charles Shang (USA)</span></p><p><span style="font-size: medium;">Chee-Wai Cheng (USA)</span></p><p><span style="font-size: medium;">Chih-Yao Cheng (USA)</span></p><p><span style="font-size: medium;">Daniel Bailey (USA)</span></p><p><span style="font-size: medium;">Danijela Scepanovic (Slovakia)</span></p><p><span style="font-size: medium;">Ersalan Hernandez (USA)</span></p><p><span style="font-size: medium;">Esmaeel Ghasroddashti (Canada)</span></p><p><span style="font-size: medium;">H Sudahar (India)</span></p><p><span style="font-size: medium;">He Wang (USA)</span></p><p><span style="font-size: medium;">Kanan Jassal (India)</span></p><p><span style="font-size: medium;">Lanchun Lu (USA)</span></p><p><span style="font-size: medium;">Lei Guo (USA)</span></p><p><span style="font-size: medium;">Leonardo da Silva Boia (USA)</span></p><p><span style="font-size: medium;">Luiz Antonio Ribeiro da Rosa (Brasil)</span></p><p><span style="font-size: medium;">Maria Chan (USA)</span></p><p><span style="font-size: medium;">Ming Yan (USA)</span></p><p><span style="font-size: medium;">Mohamed Fawzy (Egypt)</span></p><p><span style="font-size: medium;">Mohammad Rafiqul Islam (USA)</span></p><p><span style="font-size: medium;">Nilseia Aparecida Barbosa (Brasil)</span></p><p><span style="font-size: medium;">Nita Nair (India)</span></p><p><span style="font-size: medium;">Panayiotis Mavroidis (USA)</span></p><p><span style="font-size: medium;">Paul Sijens (Netherlands)</span></p><p><span style="font-size: medium;">Paulo Roberto Fonseca (Brasil)</span></p><p><span style="font-size: medium;">Pei-Hsin Cheng (USA)</span></p><p><span style="font-size: medium;">Prabhakar Ramachandran (Australia)</span></p><p><span style="font-size: medium;">Pradip Maiti (India)</span></p><p><span style="font-size: medium;">Pratik Kumar (India)</span></p><p><span style="font-size: medium;">Qinghui Zhang (USA)</span></p><p><span style="font-size: medium;">Qiyong Fan (USA)</span></p><p><span style="font-size: medium;">Radu Alin Vasilache (Romania)</span></p><p><span style="font-size: medium;">Rajesh Thiyagarajan (India)</span></p><p><span style="font-size: medium;">Ranjita Shegokar (Germany)</span></p><p><span style="font-size: medium;">Rick Sims (New Zeland)</span></p><p><span style="font-size: medium;">Sara Bresciani (Italy)</span></p><p><span style="font-size: medium;">Saurabh Varshney (India)</span></p><p><span style="font-size: medium;">Shyam Pokhrel (USA)</span></p><p><span style="font-size: medium;">Sunder Goyal (India)</span></p><p><span style="font-size: medium;">Supriya Chopra (India)</span></p><p><span style="font-size: medium;">Suresh Rana (USA)</span></p><p><span style="font-size: medium;">Toks Yerokun (USA)</span></p><p><span style="font-size: medium;">Tulika Seth (USA)</span></p><p><span style="font-size: medium;">V. Kannan (India)</span></p><p><span style="font-size: medium;">Waldemar Ulmer (Germany)</span></p><p><span style="font-size: medium;">Waqas Shuaib (USA)</span></p><p><span style="font-size: medium;">Xiang-Ming Ding (USA)</span></p><p><span style="font-size: medium;">Yida Hu (USA)</span></p><p><span style="font-size: medium;">Yong Chen (USA)</span></p><p><span style="font-size: medium;">Yu Wang (USA)</span></p><p><span style="font-size: medium;">Yuanming Feng (USA)</span></p><p><span style="font-size: medium;">Yulin Song (USA)</span></p>
International Journal of Cancer Therapy and Oncology
2014-12-22 00:00:00
http://www.ijcto.org/index.php/IJCTO/article/view/Acknowledgment2014
International Journal of Cancer Therapy and Oncology; Vol 2, No 4 (2014): October - December
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/80
2014-04-12T11:23:44Z
IJCTO:EDITORIAL
cam 3u
"140221 2014 eng "
dc
Splenic artery infusion of IL-2 might allow treatment of melanoma and renal cell cancer with less side effects and greater efficacy
Alisky, Joseph Martin; Senior Care of Colorado/IPC
cancer treatment
Interleukin-2; Cytokines; Treatment Protocols
immunotherapy
<p>Treatment of stave IV renal cell cancer and melanoma with intravenous interleukin-2 (IL-2) is often limited by side effects, and only a minority of patients obtain sustained remissions. This editorial proposes that infusing IL-2 into the splenic artery will allow much stronger immune activation without systemic side effects, achieving a superior clinical response and enabling treatment of patients currently excluded from IL-2 by medical comorbidities.</p><p>----------------------------------</p><p><strong>Cite this article as</strong>: Alisky JM. Splenic artery infusion of IL-2 might allow treatment of melanoma and renal cell cancer with less side effects and greater efficacy. <em>Int J Cancer Ther Oncol</em> 2014; <strong>2</strong>(1):020115.</p><p><strong>DOI:</strong> <a href="http://dx.doi.org/10.14319/ijcto.0201.15" target="_blank">http://dx.doi.org/10.14319/ijcto.0201.15</a></p><p> </p>
International Journal of Cancer Therapy and Oncology
2014-02-23 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Alisky
International Journal of Cancer Therapy and Oncology; Vol 2, No 1 (2014): January - March
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/21
2014-03-15T22:54:41Z
IJCTO:EDITORIAL
cam 3u
"130926 2013 eng "
dc
MRI and DWI: the future in cervical cancer?
Marconi, Daniel Grossi; Department of Radiation Oncology,
Barretos Cancer Hospital, Brazil.
Rauber, Erick; Department of Radiation Oncology,
Barretos Cancer Hospital, Brazil.
Soares, Paula de Cassia; Department of Radiation Oncology,
Barretos Cancer Hospital, Brazil.
Oncology
MRI; Diffusion
Cervical cancer
<div><p>This article is an editorial, and it doesn't include an abstract. Full text of this article is available in <a href="http://ijcto.org/index.php/IJCTO/article/view/Marconi/ijcto.0101.8html" target="_blank">HTML</a> and <a href="/index.php/IJCTO/article/view/Marconi/ijcto.0101.8pdf" target="_blank">PDF</a>.</p><p><strong>Cite this article as</strong>:<br />Marconi D, Rauber E, Soares P. MRI and DWI: the future in cervical cancer? <em>Int J Cancer Ther Oncol</em> 2013;<strong>1</strong>(1):01018.<br /><strong>DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0101.8" target="_self">10.14319/ijcto.0101.8</a></p><p>--------------------------------------</p></div>
International Journal of Cancer Therapy and Oncology
2013-10-10 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Marconi
International Journal of Cancer Therapy and Oncology; Vol 1, No 1 (2013): September - October
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/498
2016-01-03T12:17:08Z
IJCTO:EDITORIAL
cam 3u
"151225 2015 eng "
dc
High Impact Papers from October – December, 2014
Editorial Office, IJCTO
<p>High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em> completes the publication time period of 12 months.</p><p>Following articles are recognized as <strong>High Impact Papers</strong> from <strong><a href="/index.php/IJCTO/issue/view/15">October - December, 2014</a></strong>:</p><p> </p><p>Ojala J. The accuracy of the Acuros XB algorithm in external beam radiotherapy – a comprehensive review. Int J Cancer Ther Oncol 2014; 2(4):020417. <strong><br />DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0204.17">10.14319/ijcto.0204.17</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/0204.17">Read </a> </strong> <strong><a href="/index.php/IJCTO/article/download/0204.17/ijcto.0204.17pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=g47JHvsAAAAJ&citation_for_view=g47JHvsAAAAJ:WF5omc3nYNoC">Citations</a></strong></p><p> </p><p>Rout BK, Muralidhar KR, Ali M, Shekar MC, Kumar A. Dosimetric study of RapidArc plans with flattened beam (FB) and flattening filter-free (FFF) beam for localized prostate cancer based on physical indices. Int J Cancer Ther Oncol 2014; 2(4):02046.<strong><br />DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0204.6">10.14319/ijcto.0204.6</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/0204.6">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/0204.6/ijcto.0204.6pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=g47JHvsAAAAJ&citation_for_view=g47JHvsAAAAJ:d1gkVwhDpl0C">Citations</a></strong></p><p><strong><br /></strong></p><p><strong></strong>Rana S, Pokharel S. Dose-to-medium vs. dose-to-water: Dosimetric evaluation of dose reporting modes in Acuros XB for prostate, lung and breast cancer. Int J Cancer Ther Oncol 2014; 2(4):020421. <strong><br />DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0204.21">10.14319/ijcto.0204.21</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/0204.21">Read </a> </strong> <strong><a href="/index.php/IJCTO/article/download/0204.21/ijcto.0204.21pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=g47JHvsAAAAJ&citation_for_view=g47JHvsAAAAJ:eQOLeE2rZwMC">Citations</a></strong></p><p><strong><br /></strong></p><p><strong></strong>Petrou EI, Narayanasamy G, Lavdas E, Stathakis S, Papanikolaou N, Lind BK, Mavroidis P. Evaluation of the generalized gamma as a tool for treatment planning optimization. Int J Cancer Ther Oncol 2014; 2(4):020418.<strong><br />DOI</strong>: <strong><a href="http://dx.doi.org/10.14319/ijcto.0204.18">10.14319/ijcto.0204.18</a></strong></p><p><strong><a href="/index.php/IJCTO/article/view/0204.18">Read</a> </strong> <strong><a href="/index.php/IJCTO/article/download/0204.18/ijcto.0204.18pdf">Download</a> <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=g47JHvsAAAAJ&citation_for_view=g47JHvsAAAAJ:u5HHmVD_uO8C">Citations</a></strong></p><p> </p><p>(High impact papers from <strong><a href="/index.php/IJCTO/issue/view/16">January-March, 2015</a></strong> will be recognized in the next <em>Issue</em> of the IJCTO)</p>
International Journal of Cancer Therapy and Oncology
2015-12-30 00:00:00
http://www.ijcto.org/index.php/IJCTO/article/view/impact0204
International Journal of Cancer Therapy and Oncology; Vol 3, No 4 (2015): October - December
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/327
2015-03-29T11:59:31Z
IJCTO:EDITORIAL
cam 3u
"150329 2015 eng "
dc
High Impact Papers from January – March, 2014
Office, Editorial
<p>High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em> completes the publication time period of 12 months. View in PDF</p><p>Following articles are recognized as <strong>High Impact Papers</strong> from <strong><span style="text-decoration: underline;">January-March, 2014</span></strong>:</p><p>Wang H, Vassiliev ON. Microdosimetric characterisation of radiation fields for modelling tissue response in radiotherapy. Int J Cancer Ther Oncol 2014; 2(1):020116.<strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0201.16"><strong>10.14319/ijcto.0201.16</strong></a></p><p><a href="http://www.ijcto.org/index.php/IJCTO/article/view/Wang/ijcto.0201.16html" target="_blank"><strong>Read</strong> </a> <strong><a href="http://www.ijcto.org/index.php/IJCTO/article/download/Wang/ijcto.0201.16pdf" target="_blank">Download</a> <br /></strong></p><p> </p><p>Chaikh A, Giraud J, Balosso J. A method to quantify and assess the dosimetric and clinical impact resulting from the heterogeneity correction in radiotherapy for lung cancer. Int J Cancer Ther Oncol 2014; 2(1):020110.<strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0201.10"><strong>10.14319/ijcto.0201.10</strong></a></p><p><a href="http://www.ijcto.org/index.php/IJCTO/article/view/Chaikh/ijcto.0201.10html" target="_blank"><strong>Read</strong> </a> <strong><a href="http://www.ijcto.org/index.php/IJCTO/article/download/Chaikh/ijcto.0201.10pdf" target="_blank">Download</a> <br /></strong></p><p> </p><p>Rana S. Clinical dosimetric impact of Acuros XB and analytical anisotropic algorithm (AAA) on real lung cancer treatment plans: review. Int J Cancer Ther Oncol 2014; 2(1):02019.<strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0201.9"><strong>10.14319/ijcto.0201.9</strong></a><strong> <br /></strong></p><p><a href="http://www.ijcto.org/index.php/IJCTO/article/view/Rana1/ijcto.0201.9html" target="_blank"><strong>Read</strong> </a> <strong><a href="http://www.ijcto.org/index.php/IJCTO/article/download/Rana1/ijcto.0201.9pdf" target="_blank">Download</a> <br /></strong></p><p> </p><p>(High impact papers from <a href="/index.php/IJCTO/issue/view/13"><strong>April-June, 2014</strong></a> will be recognized in the next <em>Issue</em> of the IJCTO)</p>
International Journal of Cancer Therapy and Oncology
2015-03-29 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/impact21
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/73
2014-05-25T16:30:38Z
IJCTO:EDITORIAL
cam 3u
"140325 2014 eng "
dc
The results of 2013 survey to evaluate Laparoscopic and Partial nephrectomy practice in the United Kingdom
Vasdev, Nikhil; Hertfordshire and South Bedfordshire Urological Robotic Cancer Centre, Lister Hospital, UK.
Mafeld, Sebastian; Department of Urology, Freeman Hospital, Newcastle upon Tyne
Fuge, Oliver; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Lane, Timothy; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Boustead, Gregory; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Adshead, James; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Soomro, Naeem; Department of Urology, Freeman Hospital, Newcastle upon Tyne
Urology
Laparoscopic Partial Nephrectomy, Robotic Partial Nephrectomy, UK, National questionnaire
Partial Nephrectomy
<p>This article is an editorial, and it doesn't include an abstract. Full text of this article is available in <a href="/index.php/IJCTO/article/view/02022/ijcto.0202.2html" target="_blank"><strong>HTML</strong></a> and <a href="/index.php/IJCTO/article/view/02022/ijcto.0202.2pdf" target="_blank"><strong>PDF</strong></a>.</p><p><strong>Cite this article as:</strong> Vasdev N, Mafeld S, Fuge O, Lane T, Boustead G, Adshead JM, Soomro NA. The results of 2013 survey to evaluate laparoscopic and partial nephrectomy practice in the United Kingdom. <em>Int J Cancer Ther Oncol</em> 2014; <strong>2</strong>(2):02022.</p><p><strong>DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0202.2" target="_blank">http://dx.doi.org/10.14319/ijcto.0202.2</a></p>
International Journal of Cancer Therapy and Oncology
Nik
2014-03-25 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/02022
International Journal of Cancer Therapy and Oncology; Vol 2, No 2 (2014): April - June
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/22
2014-03-15T22:18:42Z
IJCTO:EDITORIAL
cam 3u
"131002 2013 eng "
dc
Clinical implementation of radiobiological measures in treatment planning. Why has it taken so long?
Mavroidis, Panayiotis; Division of Medical Physics, Department of Radiation Oncology, Cancer Therapy and Research Center, University of Texas Health Sciences Center San Antonio, San Antonio TX, USA.
Medical Physics
This article is an editorial, and it doesn't include an abstract. Full text of this article is available in <a href="/index.php/IJCTO/article/view/Mavroidis/ijcto.0101.9html" target="_blank">HTML</a> and <a href="/index.php/IJCTO/article/view/Mavroidis/ijcto.0101.9pdf" target="_blank">PDF</a>.<br /><p><strong>Cite this article as</strong>:<br />Mavroidis P. Clinical implementation of radiobiological measures in treatment planning. Why has it taken so long? <em>Int J Cancer Ther Oncol</em> 2013;<strong>1</strong>(1):01019.<br /><strong>DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0101.9" target="_self">10.14319/ijcto.0101.9</a></p><p>--------------------------------</p>
International Journal of Cancer Therapy and Oncology
2013-10-10 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Mavroidis
International Journal of Cancer Therapy and Oncology; Vol 1, No 1 (2013): September - October
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/572
2016-07-16T06:21:53Z
IJCTO:EDITORIAL
cam 3u
"160330 2016 eng "
dc
High Impact Papers from January – March, 2015
Office, Editorial
<p>High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em> completes the publication time period of 12 months.</p><p>Following articles are recognized as High Impact Papers from <span style="text-decoration: underline;">January-March, 2015</span>:</p><p>Jassal K, Sarkar B, Munshi A, Roy S, Paul S, Mohanti BK, Ganesh T, Chougule A, Sachdev K. Consistency analysis for the performance of planar detector systems used in advanced radiotherapy. Int J Cancer Ther Oncol. 2015; 3(1):030110. <br />DOI: 10.14319/ijcto.0301.10</p><p><a href="/index.php/IJCTO/article/view/0301.10" target="_blank">Read</a> <a href="/index.php/IJCTO/article/download/0301.10/ijcto.0301.10pdf" target="_blank">Download</a> </p><p> </p><p>Khanal SP, Ouhib Z, Benda RK, Leventouri T. Evaluation of surface dose outside the treatment area for five breast cancer irradiation modalities using thermo-luminescent dosimeters. Int J Cancer Ther Oncol 2015; 3(1):030117. <br />DOI: 10.14319/ijcto.0301.17</p><p><a href="/index.php/IJCTO/article/view/0301.17" target="_blank">Read</a> <a href="/index.php/IJCTO/article/download/0301.17/ijcto.0301.17pdf" target="_blank">Download </a> </p><p> </p><p>(High impact papers from <a href="/index.php/IJCTO/issue/view/17">April-June, 2015</a> will be recognized in the next <em>Issue</em> of the IJCTO)</p>
International Journal of Cancer Therapy and Oncology
2016-03-30 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/impact31
International Journal of Cancer Therapy and Oncology; Vol 4, No 1 (2016): January - March
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/333
2015-03-29T12:04:13Z
IJCTO:EDITORIAL
cam 3u
"150329 2015 eng "
dc
Journal of Proton Therapy: Call for Papers
Proton Therapy, Journal of
<p><strong><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #0000ff;">Journal of Proton Therapy (JPT) </span></span></span></span></span></span></span></span></strong></strong>is an international open access, peer-reviewed journal, which publishes original research, technical reports, reviews, case reports, editorials, and other materials on proton therapy with focus on radiation oncology, medical physics, medical dosimetry, and radiation therapy.</p><ul><li>No article processing/submission fee</li><li>No publication fee</li><li>Peer-review completion within 3-6 weeks</li><li>Immediate publication after the completion of final author proofread</li><li>DOI assignment for each published article</li><li>Free access to published articles for all readers without any access barriers or subscription</li></ul><p>The views and opinions expressed in articles are those of the author/s and do not necessarily reflect the policies of the Journal of Proton Therapy.</p><p><strong>Authors are encouraged to submit articles for publication in the inaugural issue of the <em><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #0000ff;">Journal of Proton Therapy </span></span></span></span></span></span></span></span></strong></span></span></span></span></span></span></span></strong></em></strong>by <a href="http://www.protonjournal.org/index.php/jpt/about/submissions#onlineSubmissions" target="_blank">online</a> or email to <em><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #0000ff;">editor@protonjournal.com</span></span></span></span></span></span></span></span></strong></span></span></span></span></span></span></span></strong></em></p><p>For more information, please visit <em><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #0000ff;"><br /><a href="http://www.protonjournal.com/" target="_blank">www. protonjournal.com</a><br /><em><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #0000ff;"><a href="http://www.protonjournal.org/" target="_blank">www. protonjournal.org </a><br /></span></span></span></span></span></span></span></span></strong></span></span></span></span></span></span></span></strong></em> <br /></span></span></span></span></span></span></span></span></strong></span></span></span></span></span></span></span></strong></em></p><p><strong>**************************************</strong></p><table class="announcements"><tbody><tr class="title"><td class="title"><h4><strong>Journal of Proton Therapy Welcomes <a href="http://www.protonjournal.org/index.php/jpt/pages/view/editorialboard" target="_blank">Editorial Board</a> Members</strong></h4></td><td class="more"> </td></tr><tr class="description"><td class="description"><p><strong>Chee-Wai Cheng, PhD</strong><strong><br /> </strong>Dr. Cheng is the Director of Proton Medical Physics at the University Hospitals as well as Professor of Clinical Radiation Oncology at the Case Western Reserve University, Cleveland, Ohio, USA.</p><p><strong>Carlos Vargas, MD</strong><br />Dr. Vargas is a Radiation Oncologist at the Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona. </p><p><strong>Luca Cozzi, PhD</strong><strong><br /> </strong>Dr. Cozzi is a Clinical Research Scientist at the Department of Radiotherapy and Radiosurgery at Humanitas Cancer Center, Milan, Italy.</p><p><strong>Ted Ling, MD</strong><strong><br /> </strong>Dr. Ling is a Resident Physician at the Department of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, California, USA.</p><p><strong>Haibo Lin, PhD</strong><br /> Dr. Lin is a Medical Physicist at the Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</p><p><strong>Xiaodong Zhang, PhD</strong><br /> Dr. Zhang is an Associate Professor at the Department of Radiation Physics - Patient Care, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.</p><p><strong>Alexei V. Trofimov, PhD </strong><strong><br /> </strong>Dr. Trofimov is a Radiation Physicist at the Department of Radiation Oncology, Massachusetts General Hospital (MGH) as well as Assistant Professor of Radiation Oncology at Harvard Medical School, Boston, Massachusetts, USA.</p><p><strong>Minesh Mehta, MD</strong><strong><br /> </strong>Dr. Mehta is the Medical Director at the Maryland Proton Treatment Center as well as Professor at the Department of Radiation Oncology, University of Maryland, Baltimore, Maryland, USA.</p><p><strong>Terence Sio, MD, MS</strong><strong><br /> </strong>Dr. Sio is a Resident Physician at the Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.</p><p><strong>Bijan Arjomandy, PhD</strong><strong><br /> </strong>Dr. Arjomandy is a Lead Senior Proton Medical Physicist at the McLaren Proton Therapy Center, Flint, Michigan, USA.</p><p><strong>Gino Lim, PhD</strong><strong><br /> </strong>Dr. Lim is the Department Chair and Associate Professor at the Department of Industrial Engineering, University of Houston, Houston, Texas, USA.</p><p><strong>Wayne D. Newhauser, PhD</strong><br /> Dr. Newhauser is the Professor and Director of Medical Physics and Health Physics at Louisiana State University, Baton Rouge, Louisiana, USA.</p><p><strong>Shikui Tang, PhD</strong><br /> Dr. Tang is a Medical Physicist at ProCure Proton Therapy Center, Somerset, New Jersey, USA.</p><p><strong>David Mansur, MD<br /> </strong>Dr. Mansur is a Division Chief at Radiation Oncology, Case Western Reserve University School of Medicine, University Hospitals Seidman Cancer Center, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.</p><p><strong>Barbara Rombi, MD<br /> </strong>Dr. Rombi is an Attending Physician at Proton Therapy Center, S. Chiara Hospital, Trento, Italy.</p><p><strong>Cole Kreofsky, MD<br /> </strong>Dr. Kreofsky is a Resident Physician at the Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.</p><p><strong>Lane Rosen, MD<br /></strong>Dr. Rosen is a Radiation Oncologist at the Department of Radiation Oncology, Willis-Knighton Cancer Center, Shreveport, Louisiana, USA.</p><p><strong>Charles Bloch, PhD</strong><br />Dr. Bloch is an Associate Professor at the Department of Radiation Oncology, University of Washington, Seattle, WA, USA.</p><p><strong>Wei Liu, PhD</strong><br />Dr. Liu is an Assistant Professor of Radiation Oncology at Mayo Clinic, Phoenix, Arizona, USA.</p></td></tr></tbody></table><p><strong><br /></strong></p><p><em><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><strong><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #000000; font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 14px;"><span style="font-family: Cambria,'Hoefler Text','Liberation Serif',Times,'Times New Roman',serif; font-size: 12px;"><span style="color: #0000ff;"><br /></span></span></span></span></span></span></span></span></strong></span></span></span></span></span></span></span></strong></em></p>
International Journal of Cancer Therapy and Oncology
2015-03-29 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/jpt
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/167
2014-08-16T18:42:02Z
IJCTO:EDITORIAL
cam 3u
"140816 2014 eng "
dc
High Impact Papers from September – October, 2013 (Issue 1)
Office, Editorial; International Journal of Cancer Therapy and Oncology (IJCTO)
<p>High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em> completes the publication time period of 12 months.</p><p>Full text is available in <a href="/index.php/IJCTO/article/download/impact0101/HighImpactPaper0101" target="_blank"><strong>PDF</strong></a></p>
International Journal of Cancer Therapy and Oncology
2014-08-16 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/impact0101
International Journal of Cancer Therapy and Oncology; Vol 2, No 3 (2014): July - September
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/32
2014-03-16T22:06:02Z
IJCTO:EDITORIAL
cam 3u
"131122 2013 eng "
dc
Dose calculation algorithms in external beam photon radiation therapy
Lu, Lanchun; Department of Radiation Oncology, The James Cancer Hospital, Ohio State University, Columbus, Ohio, USA.
Radiation Oncology; Medical Physics; Medical Dosimetry
<p>This article is an editorial, and it doesn't include an abstract. Full text of this article is also available in <a href="/index.php/IJCTO/article/view/Lu/ijcto.0102.5html" target="_blank"><strong>HTML</strong></a> and <a href="/index.php/IJCTO/article/view/Lu/ijcto.0102.5pdf" target="_blank"><strong>PDF</strong></a>.</p><p><strong>Cite this article as:</strong><br />Lu L. Dose calculation algorithms in external beam photon radiation therapy. Int J Cancer Ther Oncol 2013; <strong>1</strong>(2):01025.</p><p><strong>DOI:</strong> <a href="http://dx.doi.org/10.14319/ijcto.0102.5" target="_self">http://dx.doi.org/10.14319/ijcto.0102.5</a></p><p> </p>
International Journal of Cancer Therapy and Oncology
2013-12-04 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Lu
International Journal of Cancer Therapy and Oncology; Vol 1, No 2 (2013): November - December
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/573
2016-07-16T06:01:38Z
IJCTO:EDITORIAL
cam 3u
"160630 2016 eng "
dc
High Impact Papers from April – June, 2015
Office, Editorial
High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em>completes the publication time period of 12 months.<div class="WordSection2"><p>Following articles are recognized as High Impact Papers from <span style="text-decoration: underline;">April - June, 2015</span>:</p><p>Vazquez-Quino L, Huerta-Hernandez C, Calvo O, Deweese M. Evaluation of a novel reference chamber “stealth chamber” through Monte Carlo simulations and experimental data. Int J Cancer Ther Oncol 2015; 3(2):3222. <br />DOI: <a href="http://dx.doi.org/10.14319/ijcto.32.22">10.14319/ijcto.32.22</a></p><p><a href="/index.php/IJCTO/article/view/ijcto.32.22">Read </a> <a href="/index.php/IJCTO/article/download/ijcto.32.22/ijcto.32.22pdf">Download</a> </p><p> </p><p>Narayanasamy G, Feddock J, Gleason J, McGarry R, Molloy J. CBCT-based dosimetric verification and alternate planning techniques to reduce the normal tissue dose in SBRT of lung patients. Int J Cancer Ther Oncol 2015; 3(2):3218. <br />DOI: <a href="http://dx.doi.org/10.14319/ijcto.32.18">10.14319/ijcto.32.18</a></p><p><a href="/index.php/IJCTO/article/view/ijcto.32.18">Read</a> <a href="/index.php/IJCTO/article/download/ijcto.32.18/ijcto.32.18pdf">Download</a> </p><p> </p><p>Adams B, Herold M, Ferstl E, Choi J, Zhu S, Bogdanov V, El-Rayes B, Sun A, Liotta D, Snyder J, Shoji M. Anticancer effects of monocarbonyl analogs of curcumin: Oxidative stress, nuclear translocation and modulation of AP-1 and NF-κB. Int J Cancer Ther Oncol 2015; 3(2):3219.<br />DOI: <a href="http://dx.doi.org/10.14319/ijcto.32.19">10.14319/ijcto.32.19</a></p><p><a href="/index.php/IJCTO/article/view/ijcto.32.19">Read</a> <a href="/index.php/IJCTO/article/download/ijcto.32.19/ijcto.32.19pdf">Download</a> </p><p> </p><p>(High impact papers from <a href="/index.php/IJCTO/issue/view/18">July-September, 2015</a> will be recognized in the next <em>Issue</em> of the IJCTO)</p></div>
International Journal of Cancer Therapy and Oncology
2016-06-30 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/impact32
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/403
2015-08-15T11:55:57Z
IJCTO:EDITORIAL
cam 3u
"150630 2015 eng "
dc
High Impact Papers from April – June, 2014
Editorial Office, IJCTO
High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue</em>completes the publication time period of 12 months.<p>Following articles are recognized as <strong>High Impact Papers</strong> from <strong><span style="text-decoration: underline;"><a href="/index.php/IJCTO/issue/view/13">April-June, 2014</a></span></strong>:</p><p> </p><p>Rana S, Pokharel S, Zheng Y, Zhao L, Risalvato D, Vargas C, Cersonsky N. Treatment planning study comparing proton therapy, RapidArc and intensity modulated radiation therapy for a synchronous bilateral lung cancer case. Int J Cancer Ther Oncol 2014; 2(2):020216. <strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0202.16"><strong>10.14319/ijcto.0202.16</strong></a></p><p><strong><a href="http://dx.doi.org/10.14319/ijcto.0202.16">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/020216/ijcto.0202.16pdf">Download</a> <a href="https://scholar.google.com/scholar?cites=2700853685510969486&as_sdt=5,37&sciodt=0,37&hl=en">Citations</a></strong></p><p> </p><p>Ulmer W. A new calculation formula of the nuclear cross-section of therapeutic protons. Int J Cancer Ther Oncol 2014; 2(2):020211. <strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0202.11"><strong>10.14319/ijcto.0202.11</strong></a></p><p><strong><a href="http://dx.doi.org/10.14319/ijcto.0202.11">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/020211/ijcto.0202.11pdf">Download</a> <a href="https://scholar.google.com/scholar?cites=5052158883124985135&as_sdt=5,37&sciodt=0,37&hl=en">Citations</a></strong></p><p><strong><br /></strong></p><p><strong></strong>Wu D, Wei S, Luo C, Wu X, Feng Y, Zhang F, Nie L, Xia X. Clinical study on the sensitivity test guided hepato-arterial/portal -vein chemotherapy in patients with unresectable hepatocellar carci-noma. Int J Cancer Ther Oncol 2014; 2(2):02029. <strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0202.9"><strong>10.14319/ijcto.0202.9</strong></a></p><p><strong><a href="http://dx.doi.org/10.14319/ijcto.0202.9">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/Wu/ijcto.0202.9pdf">Download</a> <a href="https://scholar.google.com/scholar?q=ijcto.0202.9&btnG=&hl=en&as_sdt=0%2C37">Citations</a></strong></p><p> </p><p>Amankwaa-Frempong E, Vernimmen F, Blay S, Ezhilalan R. Irradiation of lung and esophagus tumors: A comparison of dose distributions calculated by anisotropic analytical algorithm and pencil beam convolution algorithm, a retrospective dosimetric study. Int J Cancer Ther Oncol 2014; 2(2):020210. <strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0202.10"><strong>10.14319/ijcto.0202.10</strong></a></p><p><strong><a href="http://dx.doi.org/10.14319/ijcto.0202.10">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/Frempong/ijcto.0202.10pdf">Download</a> <a href="https://scholar.google.com/scholar?cites=12146211130276680343&as_sdt=5,37&sciodt=0,37&hl=en">Citations</a></strong></p><p><strong><br /></strong></p><p><strong></strong>Jassal K, Munshi A, Sarkar B, Paul S, Sharma A, Mohanti BK, Ganesh T, Chougule A, Sachdev K. Validation of an integrated patient positioning system: Exactrac and iViewGT on Synergy Platform. Int J Cancer Ther Oncol 2014; 2(2):020212. <strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0202.12"><strong>10.14319/ijcto.0202.12</strong></a></p><p><strong><a href="http://dx.doi.org/10.14319/ijcto.0202.12">Read</a></strong> <strong><a href="/index.php/IJCTO/article/download/Jassal/ijcto.0202.12pdf">Download</a> <a href="https://scholar.google.com/scholar?cites=1471675953699294005&as_sdt=5,37&sciodt=0,37&hl=en">Citations</a></strong></p><p> </p><p>(High impact papers from <a href="/index.php/IJCTO/issue/view/14"><strong>July-September, 2014</strong></a> will be recognized in the next <em>Issue</em> of the IJCTO)</p>
International Journal of Cancer Therapy and Oncology
2015-01-22 00:00:00
application/force-download
http://www.ijcto.org/index.php/IJCTO/article/view/impact22
International Journal of Cancer Therapy and Oncology; Vol 3, No 2 (2015): April - June
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/168
2014-08-16T18:42:02Z
IJCTO:EDITORIAL
cam 3u
"140816 2014 eng "
dc
Conferences and Meetings in 2014
Office, Editorial; International Journal of Cancer Therapy and Oncology (IJCTO)
Full text is available in <a href="/index.php/IJCTO/article/download/conf2014a/Conf2014" target="_blank"><strong>PDF</strong></a>
International Journal of Cancer Therapy and Oncology
2014-08-16 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/conf2014a
International Journal of Cancer Therapy and Oncology; Vol 2, No 3 (2014): July - September
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/42
2014-03-16T22:40:11Z
IJCTO:EDITORIAL
cam 3u
"131202 2013 eng "
dc
Recent advances in treatment of childhood cancer : role of targeted therapy
Al-Tonbary, Youssef; Department of Pediatric Oncology, Mansoura University, Daqahlia
<p>This article is an editorial, and it doesn't include an abstract. Full text of this article is also available in <a href="/index.php/IJCTO/article/view/Al-Tonbary/ijcto.0102.8html" target="_blank">HTML</a> and <a href="/index.php/IJCTO/article/view/Al-Tonbary/ijcto.0102.8pdf" target="_blank">PDF</a>.</p><p><strong>Cite this article as</strong>: <br />Al-Tonbary Y. Recent advances in treatment of childhood cancer: role of targeted therapy. Int J Cancer Ther Oncol 2013; <strong>1</strong>(2):01028.</p><p><strong>DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0102.8" target="_blank">http://dx.doi.org/10.14319/ijcto.0102.8</a></p>
International Journal of Cancer Therapy and Oncology
2013-12-04 00:00:00
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Al-Tonbary
International Journal of Cancer Therapy and Oncology; Vol 1, No 2 (2013): November - December
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/447
2016-01-03T12:17:08Z
IJCTO:EDITORIAL
cam 3u
"151208 2015 eng "
dc
Some patients with advanced malignancies also have reversible catatonia or limbic encephalitis
Alisky, Joseph Martin; Senior Care of Colorado/IPC, 1400 South Potomac Street, Suite 150, Aurora, Colorado
Medical Oncology
Catatonia; Limbic Encephalitis; Anti NMDA-receptor Encephalitis
Hospice care
<p class="Standard">Two potentially treatable disorders, paraneoplastic catatonia and paraneoplastic limbic encephalitis, may be hidden within the presentation of end stage cancer patients, because catatonia and limbic encephalitis usually feature severely altered mental status, confusion, anorexia, and minimal responsiveness that are also common with people dying of cancer. If catatonia and limbic encephalitis are correctly diagnosed and treated, there should be definite and dramatic improvement that would translate into better quality of life and perhaps even resumption of cancer therapy. This editorial reviews basic features of catatonia and limbic encephalitis, and then presents a strategy to systematically screen for these in end stage cancer patients who are about to enter hospice. A protocol is outlined that could be adapted for clinical practice or for designing clinical studies.</p>
International Journal of Cancer Therapy and Oncology
2015-12-30 00:00:00
application/force-download
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.34.13
International Journal of Cancer Therapy and Oncology; Vol 3, No 4 (2015): October - December
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/231
2015-03-29T09:39:21Z
IJCTO:EDITORIAL
cam 3u
"141030 2014 eng "
dc
High Impact Papers from November – December, 2013
Office, Editorial
High impact papers from a particular <em>Issue</em> are selected based on the quality of the article and the number of citations. High impact papers are typically recognized once the <em>Issue </em>completes the publication time period of 12 months. View in <a href="/index.php/IJCTO/article/download/impact0102/ijcto.0102pdf" target="_blank"><strong>PDF</strong></a><br /><div><p>Following articles are recognized as High Impact Papers from <a href="/index.php/IJCTO/issue/view/9" target="_blank"><strong><span style="text-decoration: underline;">November-December, 2013</span></strong></a>.</p><p><strong>Lu L. Dose calculation algorithms in external beam photon radiation therapy. <em>Int J Cancer Ther Oncol</em> 2013; 1(2):01025.</strong><br /><strong>DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0102.5"><strong>10.14319/ijcto.0102.5</strong></a><strong></strong></p><p><a href="/index.php/IJCTO/article/view/Lu/ijcto.0102.5html" target="_blank"><strong>Read</strong></a> <strong><a href="/index.php/IJCTO/article/download/Lu/ijcto.0102.5pdf" target="_blank">Download</a> <a href="http://scholar.google.com/scholar?oi=bibs&hl=en&cites=69568978679751605&as_sdt=5" target="_blank">Citations<br /><br /></a></strong></p><p><strong>Khosa F, Khan A, Shuaib W, Clouse M, Budoff M, Blankstein R, Nasir K. Radiation exposure for coronary artery calcium score at prospective 320 row multi-detector computed tomography. <em>Int J Cancer Ther Oncol </em>2013; 1(2):01023.</strong><strong><br />DOI</strong>: <a href="http://dx.doi.org/10.14319/ijcto.0102.3"><strong>10.14319/ijcto.0102.3</strong></a></p><p><a href="/index.php/IJCTO/article/view/Khosa/ijcto.0102.3html" target="_blank"><strong>Read</strong> </a> <strong><a href="/index.php/IJCTO/article/download/Khosa/ijcto.0102.3pdf" target="_blank">Download </a> <a href="http://scholar.google.com/scholar?oi=bibs&hl=en&cites=3752779046215046769&as_sdt=5" target="_blank">Citations</a></strong></p><p>(High impact papers from <strong><span style="text-decoration: underline;">January-March, 2014</span></strong> will be recognized in the next <em>Issue</em> of the IJCTO)</p></div>
International Journal of Cancer Therapy and Oncology
2014-12-22 00:00:00
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/impact0102
International Journal of Cancer Therapy and Oncology; Vol 2, No 4 (2014): October - December
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).